Immunopathogenesis of recurrent vulvovaginal candidiasis.
نویسندگان
چکیده
منابع مشابه
Evidence-Based Management of Recurrent Vulvovaginal Candidiasis
Vulvo-vaginal candidiasis (VVC) is a common infection among women. 5-8% of women with acute infection experience recurrent vulvo-vaginal candidiasis (RVVC). There is currently no gold standard treatment for RVVC. Although antifungal agents such as imidazoles have been successfully used as first-line treatment for acute VVC, the effectiveness of these medications is limited for RVVC, and various...
متن کاملProbiotics for prevention of recurrent vulvovaginal candidiasis: a review.
Vulvovaginal candidiasis (VVC) is a common infection affecting the quality of life of many women. Probiotics have been investigated as possible agents for the prevention of recurrences of VVC. We reviewed the available literature. In some studies the development of VVC was associated with either a low number of lactobacilli in the vagina or with the presence of H2O2-non-producing vaginal lactob...
متن کاملThe Recurrent Vulvovaginal Candidiasis: Proposal of a Personalized Therapeutic Protocol
Background. Recurrent vulvovaginal candidiasis (RVC) is an increasing challenge in clinical practice. Objective. The purpose of this study was to reduce the episodes of RVC through the intake of fluconazole 200 mg/dose with a personalized regimen at growing administration intervals with a probiotic. Method. 55 patients received a 200 mg fluconazole as an induction dose for 3 alternate days. Sym...
متن کاملWhat to do with the patient with recurrent vulvovaginal candidiasis.
The problem Genital infection with candida species is common in women, 75% of whom will have had at least one episode during their lives. Indeed, there is a 15–20% point prevalence of asymptomatic candida carriage in young, nonpregnant, premenopausal women. While acute episodes of candidal vulvovaginitis usually respond rapidly to treatment, some women suVer frequent recurrences or chronic infe...
متن کاملBoric acid for recurrent vulvovaginal candidiasis: the clinical evidence.
BACKGROUND Recurrent vulvovaginal candidiasis (VVC) remains a challenge to manage in clinical practice. Recent epidemiologic studies indicate that non-albicans Candida spp. are more resistant to conventional antifungal treatment with azoles and are considered as causative pathogens of vulvovaginal candidiasis. METHODS We searched PubMed and Scopus for studies that reported clinical evidence o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical microbiology reviews
سال: 1996
ISSN: 0893-8512
DOI: 10.1128/cmr.9.3.335-348.1996